CardioDx, Core Diagnostics India Reach Agreement to Offer CAD Test in India | GenomeWeb

NEW YORK (GenomeWeb News) – CardioDx today announced a deal with Core Diagnostics India for the marketing and sale of CardioDx's coronary artery disease test in India.

Under the terms of the deal, Core will make CardioDx's Corus CAD diagnostic test available to patients in India, which CardioDx said has one of the highest rates of CAD in the world. Blood samples collected for the test will be sent to the Palo Alto, Calif.-based firm's CLIA laboratory for analysis and turnaround.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.